188 related articles for article (PubMed ID: 35286780)
1. Vascularized Lung Cancer Model for Evaluating the Promoted Transport of Anticancer Drugs and Immune Cells in an Engineered Tumor Microenvironment.
Kim D; Hwang KS; Seo EU; Seo S; Lee BC; Choi N; Choi J; Kim HN
Adv Healthc Mater; 2022 Jun; 11(12):e2102581. PubMed ID: 35286780
[TBL] [Abstract][Full Text] [Related]
2. 3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing.
Ahn J; Kim DH; Koo DJ; Lim J; Park TE; Lee J; Ko J; Kim S; Kim M; Kang KS; Min DH; Kim SY; Kim Y; Jeon NL
Acta Biomater; 2023 Jul; 165():153-167. PubMed ID: 36243378
[TBL] [Abstract][Full Text] [Related]
3. Human in vitro vascularized micro-organ and micro-tumor models are reproducible organ-on-a-chip platforms for studies of anticancer drugs.
Liu Y; Sakolish C; Chen Z; Phan DTT; Bender RHF; Hughes CCW; Rusyn I
Toxicology; 2020 Dec; 445():152601. PubMed ID: 32980478
[TBL] [Abstract][Full Text] [Related]
4. A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy.
Ascheid D; Baumann M; Pinnecker J; Friedrich M; Szi-Marton D; Medved C; Bundalo M; Ortmann V; Öztürk A; Nandigama R; Hemmen K; Ergün S; Zernecke A; Hirth M; Heinze KG; Henke E
Nat Commun; 2024 Apr; 15(1):3599. PubMed ID: 38678014
[TBL] [Abstract][Full Text] [Related]
5. New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay.
Wan Z; Floryan MA; Coughlin MF; Zhang S; Zhong AX; Shelton SE; Wang X; Xu C; Barbie DA; Kamm RD
Adv Healthc Mater; 2023 Jun; 12(14):e2201784. PubMed ID: 36333913
[TBL] [Abstract][Full Text] [Related]
6. Enabling perfusion through multicellular tumor spheroids promoting lumenization in a vascularized cancer model.
Park J; Kim S; Hong J; Jeon JS
Lab Chip; 2022 Nov; 22(22):4335-4348. PubMed ID: 36226506
[TBL] [Abstract][Full Text] [Related]
7. 3D Bioprinted Vascularized Tumour for Drug Testing.
Han S; Kim S; Chen Z; Shin HK; Lee SY; Moon HE; Paek SH; Park S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340319
[TBL] [Abstract][Full Text] [Related]
8. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
9. Vascularized cancer on a chip: The effect of perfusion on growth and drug delivery of tumor spheroid.
Nashimoto Y; Okada R; Hanada S; Arima Y; Nishiyama K; Miura T; Yokokawa R
Biomaterials; 2020 Jan; 229():119547. PubMed ID: 31710953
[TBL] [Abstract][Full Text] [Related]
10. Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery.
Agarwal P; Wang H; Sun M; Xu J; Zhao S; Liu Z; Gooch KJ; Zhao Y; Lu X; He X
ACS Nano; 2017 Jul; 11(7):6691-6702. PubMed ID: 28614653
[TBL] [Abstract][Full Text] [Related]
11. In vitro modeling of solid tumor interactions with perfused blood vessels.
Kwak TJ; Lee E
Sci Rep; 2020 Nov; 10(1):20142. PubMed ID: 33214583
[TBL] [Abstract][Full Text] [Related]
12. Engineering a Vascularized Hypoxic Tumor Model for Therapeutic Assessment.
Ando Y; Oh JM; Zhao W; Tran M; Shen K
Cells; 2021 Aug; 10(9):. PubMed ID: 34571851
[TBL] [Abstract][Full Text] [Related]
13. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
14. All-in-one microfluidic design to integrate vascularized tumor spheroid into high-throughput platform.
Kim Y; Ko J; Shin N; Park S; Lee SR; Kim S; Song J; Lee S; Kang KS; Lee J; Jeon NL
Biotechnol Bioeng; 2022 Dec; 119(12):3678-3693. PubMed ID: 36043394
[TBL] [Abstract][Full Text] [Related]
15. Vascularized Tumor Spheroid-on-a-Chip Model Verifies Synergistic Vasoprotective and Chemotherapeutic Effects.
Hu Z; Cao Y; Galan EA; Hao L; Zhao H; Tang J; Sang G; Wang H; Xu B; Ma S
ACS Biomater Sci Eng; 2022 Mar; 8(3):1215-1225. PubMed ID: 35167260
[TBL] [Abstract][Full Text] [Related]
16. Impact of a Desmoplastic Tumor Microenvironment for Colon Cancer Drug Sensitivity: A Study with 3D Chimeric Tumor Spheroids.
Goudar VS; Koduri MP; Ta YN; Chen Y; Chu LA; Lu LS; Tseng FG
ACS Appl Mater Interfaces; 2021 Oct; 13(41):48478-48491. PubMed ID: 34633791
[TBL] [Abstract][Full Text] [Related]
17. Spheroids as vascularization units: From angiogenesis research to tissue engineering applications.
Laschke MW; Menger MD
Biotechnol Adv; 2017 Nov; 35(6):782-791. PubMed ID: 28694177
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid.
Lee SW; Kwak HS; Kang MH; Park YY; Jeong GS
Sci Rep; 2018 Feb; 8(1):2365. PubMed ID: 29403007
[TBL] [Abstract][Full Text] [Related]
19. [Immune therapy and tumor angiogenesis].
Takakura N
Rinsho Ketsueki; 2020; 61(9):1440-1445. PubMed ID: 33162547
[TBL] [Abstract][Full Text] [Related]
20. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR
J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
